Chief Operating Officer
Dr Graham Burton is a seasoned pharmaceutical executive with over thirty years of global Clinical Development, Regulatory, Pharmacovigilance/Risk Management and Compliance experience.
His career includes senior roles in Celgene, Johnson and Johnson, Upjohn/Pharmacia where he oversaw over 40 global submissions in infectious diseases, CNS and oncology indications. More recently, he is the founder and Clinical Development Officer of LDN Pharma and a member of the Board of Directors of NexImmune. He joined Immodulon in September 2017 as their Chief Operating Officer.